Axa S.A. Enovis Corp Transaction History

Axa S.A.

$32.3 Billion
Q3 2024

A detailed history of Axa S.A. transactions in Enovis Corp stock. As of the latest transaction made, Axa S.A. holds 30,125 shares of ENOV stock, worth $1.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,125

Previous 20,798 44.85%

Holding current value

$1.37 Million

Previous $940,000 37.87%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$40.57 - $48.1 $378,396 - $448,628	9,327 Added 44.85%	30,125 $1.3 Million
Q2 2024 Aug 14, 2024	BUY	$44.56 - $62.43 $192,766 - $270,072	4,326 Added 26.26%	20,798 $940,000
Q1 2024 May 15, 2024	BUY	$55.44 - $63.8 $216,049 - $248,628	3,897 Added 30.99%	16,472 $1.03 Million
Q4 2023 Jul 16, 2024	SELL	$43.67 - $57.07 $170,181 - $222,401	-3,897 Reduced 23.66%	12,575 $704,000
Q4 2023 Feb 14, 2024	SELL	$43.67 - $57.07 $2.77 Million - $3.62 Million	-63,382 Reduced 83.44%	12,575 $704,000
Q3 2023 Nov 14, 2023	BUY	$51.65 - $65.54 $183,719 - $233,125	3,557 Added 4.91%	75,957 $4.01 Million
Q2 2023 Aug 14, 2023	SELL	$52.7 - $64.12 $79,050 - $96,180	-1,500 Reduced 2.03%	72,400 $4.64 Million
Q3 2022 Feb 14, 2023	BUY	$46.07 - $60.1 $141,296 - $184,326	3,067 Added 4.33%	73,900 $3.55 Million
Q3 2022 Nov 14, 2022	BUY	$46.07 - $60.1 $141,296 - $184,326	3,067 Added 4.33%	73,900 $3.41 Million
Q2 2022 Feb 14, 2023	SELL	$55.0 - $70.47 $168,685 - $216,131	-3,067 Reduced 4.15%	70,833 $3.9 Million
Q2 2022 Aug 15, 2022	BUY	$55.0 - $70.47 $3.9 Million - $4.99 Million	70,833 New	70,833 $3.9 Million

Others Institutions Holding ENOV

# of Institutions

311

Shares Held

60.3M

Call Options Held

1.68M

Put Options Held

693K

View Full List

About Enovis CORP

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.45B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

More about ENOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account